Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xiaoer Feireqing granules for pediatric community-acquired pneumonia (real-world multicenter cohort)
ChiCTR2200062969Phase 4Recruiting
- Sponsor
- Beijing Children's Hospital
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of xiaoerfeireqing in community-acquired pneumonia (CAP), sponsored by Beijing Children's Hospital. Primary endpoint: Clinical recovery time. Started May 2022; status: recruiting.
02
Drugs
xiaoerfeireqing
03
Conditions
community-acquired pneumonia (CAP)
Beyond the preview
Go deeper on ChiCTR2200062969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062969.